Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

Cited by

This article is cited by 1 publication

1. Singh, D., Han, M. K., Hawkins, N. M., Hurst, J. R., Kocks, J. W. H., Skolnik, N., Stolz, D., El Khoury, J., & Gale, C. P. (2024). Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review. Advances in therapy, 10.1007/s12325-024-02855-4. Advance online publication. https://doi.org/10.1007/s12325-024-02855-4